ClinicalTrials.gov
public full text
Public Domain
Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery
The purpose of this study is to compare the effectiveness of Nepafenac Ophthalmic Suspension, 0.1% eye drops to Acular LS eye drops, used before and after cataract surgery, for treating inflammation in the eye.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nepafenac 0.3% Two Study#878337
- Confirmatory Study Nepafenac 0.3%#800966
- Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery#842627
- Dexmedetomidine vs. Remifentanil Undergoing Cataract Surgery in Geriatrics#893397
- Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%#827571
Record · ID 1140453
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive